An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bioventus Inc. will report financial results for Q3 2023 on November 7, 2023. The conference call to discuss the results and provide a business update will be held at 8:30 a.m. Eastern Time. Dial 1-800-715-9871 or 1-646-307-1963 to participate. Webcast and materials will be available on the company's website.
Positive
None.
Negative
None.
DURHAM, N.C., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2023 before the market opens on Tuesday, November 7, 2023. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-800-715-9871 or 1-646-307-1963 and refer to the Bioventus Inc. Conference Call or Conference ID 4502901.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until November 6, 2024.
About Bioventus Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
When will Bioventus Inc. report financial results for Q3 2023?
Bioventus Inc. will report financial results for the third quarter of fiscal year 2023 on Tuesday, November 7, 2023.
What time is the conference call to discuss the financial results?
The conference call to discuss the financial results and provide a business update will be held at 8:30 a.m. Eastern Time.
How can I participate in the conference call?
To participate in the conference call, dial 1-800-715-9871 or 1-646-307-1963 and refer to the Bioventus Inc. Conference Call or Conference ID 4502901.
Where can I access the webcast and accompanying materials?
A live webcast of the conference call and accompanying materials will be provided on the "Investor Relations" section of the Bioventus Inc. website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until November 6, 2024.
bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. bioventus accomplishes this with its orthobiologic products for musculoskeletal healing, regeneration and related biosurgery that engage and enhance the body’s natural healing processes. the company has two product portfolios for orthobiologics, bioventus active healing therapies and bioventus surgical, which are created through a combination of internal product development, product/business acquisition, and distribution agreements. established in 2012, bioventus is privately held and headquartered in durham, nc. the company has nearly 600 employees worldwide and its international headquarters is in hoofddorp, the netherlands. bioventus also has offices in memphis, tn, australia and canada, and a research and development site is located in boston. bioventus works with patients, payers and health care providers throughout the world, and generat
